Oklo Gains 2.2% After DOE Approves Groves Reactor Safety Plan, Criticality Set for July
OKLO•The U.S. Department of Energy approved Oklo’s Documented Safety Analysis for its Groves Isotope Test Reactor, clearing a major licensing hurdle ahead of scheduled criticality in July. Oklo shares rose 2.21% on the news as the company prepares to commission its first nuclear reactor this month.
1. DOE Safety Analysis Approval
The Department of Energy has approved the Documented Safety Analysis for Oklo’s Groves Isotope Test Reactor, satisfying key regulatory requirements for reactor design and operational safety. This clearance marks a critical step in Oklo’s licensing process, validating its safety protocols.
2. Reactor Criticality Timeline
Oklo aims to achieve first criticality of the Groves reactor in July, paving the way for commissioning and isotope production. The reactor is on track to go live this month, positioning Oklo at the forefront of microreactor deployment in the U.S.
3. Market Response and Next Steps
On the milestone announcement, Oklo shares climbed 2.21%, reflecting investor confidence in the company’s progress. Oklo will pursue final approvals and begin operational testing following criticality to advance commercial operations.
